Free-radical oxidation and atherosclerosis
Abstract
The important biological role reactive oxyradicals is described which are generated in various cells of able-bodied organisms, from unicellular up to highorganized, carrying out, due to a highest chemical reactivity and rather short lifetime, vital function alarm endocellular messengers and intercellular mediators for realization of the expedited and deferred adaptable rearrangement of a metabolism in tissues, including in system of a circulation. At the same time at appreciable accumulation in an organism of such moleculas them mediator function is transformed in damaging, caused by
oxidation and destruction of histic lipids, proteins and nucleic acids with development of pathological damages of members and tissues. This concept is compounded with the numerous clinical items of information, that at the patients by an essential hypertension, atherosclerosis, ischemic illness of heart and myocardial infarction histic and the plasma level reactive oxyradicals and products oxidative damage cell’s biopolimers is many times higher than sizes observable at the able-bodied people even in the term of extreme situations, and pathological important in this case acts local and – or systemic hyperproduction of superoxidic and hydroxyl radicals, peroxinitrit, oxide of nitrogen, and other awake forms of oxygen.
About the Authors
E. N. Vorobiova
Roszdrav; RAMS
Russian Federation
Russian Federation
SB RAMS
Altai State Medical University
Research Institute of Therapy
Altai Laboratory of Epidemiology, Forecasting and Prevention of Non-Communicable Diseases Noncommunicable diseases
Barnaul
G. I. Simonova
Roszdrav; RAMS
Russian Federation
Russian Federation
SB RAMS
Altai State Medical University
Research Institute of Therapy
Altai Laboratory of Epidemiology, Forecasting and Prevention of Non-Communicable Diseases Noncommunicable diseases
Barnaul
R. I. Vorobiov
Roszdrav; RAMS
Russian Federation
Russian Federation
SB RAMS
Altai State Medical University
Research Institute of Therapy
Altai Laboratory of Epidemiology, Forecasting and Prevention of Non-Communicable Diseases Noncommunicable diseases
Barnaul
I. G. Leschenko
Roszdrav; RAMS
Russian Federation
Russian Federation
SB RAMS
Altai State Medical University
Research Institute of Therapy
Altai Laboratory of Epidemiology, Forecasting and Prevention of Non-Communicable Diseases Noncommunicable diseases
Barnaul
References
1. Щепин О. П. Основные тенденции формирования здоровья населения Российской Федерации в 1998 г. / О. П. Щепин, В. К. Овчаров, Е. П. Какорина // Пробл. социальной гигиены, здравоохранения и истории медицины. – 1999. – № 6. – С. 3–11.
2. Чазов Е. И. Проблемы лечения больных ишемической болезнью сердца / Е. И. Чазов // Терапевт. арх. – 2000. – № 9. – С. 5–9.
3. Ross R. The Pathogenesis of Atherosclerosis: An Update // Atherosclerosis Beyond Cholesterd. Hanover, 1992. 17 p.
4. Stamler J. Established major coronary risk factors // In Coronary heart disease epidemiology / Eds. M. Marmot, P. Elliott. Oxford: Oxford University Press, 1996. P. 35–62.
5. Gianturco S. H., Bradley W. A. Atherosclerosis: cell biology and lipoproteins // Current Opinion in Lipidology. 1994. Vol. 5. Р. 313–315.
6. a) Parthasarathy S., Santanam N. Potential Role of Oxidized Lipids and Lipoproteins in Antioxidant Defense // Free Rad. Res. 2000. Vol. 33. Р. 197–215; b) Parthasarathy S., Santanam N., Ramachandran S., Meilhac O. Oxidants and antioxidants in athero genesis: an appraisal // J. Lipid Res. 1999. Vol. 40. P. 2143–2157.
7. Finkel T. Oxygen radicals and signaling // Current Opinion in Cell Biology. 1998. Vol. 10. P. 248–253.
8. Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans // Free Radic. Res. 1996. Vol. 25. Р. 57–74.
9. Harrison D. G. Endothelial function and oxidant stress // Clin. Cardiol. 1997. Vol. 20. Suppl. II: II-11-II-17.
10. Howarth P. H. Pathogenic mechanisms: a rational basis for treatment // BMJ. 1998. Vol. 316. P. 758–761.
11. Luscher T. F., Noll G., Vanhoutte P. M. Endothelial dysfunction in hypertension // J. Hypertens. 1996. Vol. 14 (5). Р. 383–393.
12. Daugherty M. O., Rich G. F., Johns R. A. Vascular endothelium // Current Opinion in Anaesthesiology. 1995. N 8. P. 88–94.
13. Griendling K. K., Minieri C. A., Ollerenshaw J. D., Alexander R. W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured smooth muscle cells // Circulation Res. 1994. Vol. 74. P. 1141–1148.
14. Li H., Forstermann U. Nitric oxide in the pathogenesis of vascular disease // J. Pathol. 2000. Vol. 190. P. 244–254, 319–326.
15. Cooke J. P., Dzau V. J. Nitric oxide synthase: Role in the Genesis of Vascular Disease // Ann. Rev. Med. 1997. Vol. 48. P. 489–509.
16. Ortenblad N., Madsen K., Djurhuus M. S. Antioxidant status and lipid peroxidation after short-term maximal exercise in trained and untrained humans // Am. J. Physiol. 1997. Vol. 272 (4). Р. 1258–1263.
17. Lavreni A., Salobir B. G., Keber I. et al. Physical Training Improves Flow-Mediated Dilation in Patients With the Polymetabolic Syndrome // Arteriosclerosis, Thrombosis, and Vascular Biology. 2000. Vol. 20. P. 551–559.
18. Steinberg D. Low Density Lipoprotein Oxidation and Its Pathobiological Significance // J. Biol. Chem. 1997. Vol. 272, N 34. Р. 20963–20966.
19. Capaldo B., Guardasole V., Pardo F. et al. Abnormal Vascular Reactivity in Growth Hormone Deficiency // Circulation. 2001. Vol. 103. Р. 520–524.
20. Ouchi N., Kihara S., Arita Y. et al. Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages // Ibid. Р. 1057–1063.
21. Bredt D. S. Endogenous nitric oxide synthesis: biological functions and pathophysiology // Free Rad. Res. 1999. Vol. 31. P. 577–581.
22. Beckman J. S., Carson M., Smith C. D., Koppenol W. H. SLS, SOD and peroxynitrite // Nature. 1993. Vol. 364. P. 584–587.
23. Nathan C. F. Secretory products of macrophages // J. Clin. Invest. 1987. Vol. 79.
24. Givertz M. M., Colucci W. S. New targets for heart-failure therapy: endothelin, in-flammatory cytokines, and oxidative stress // Lancet. 1998. Vol. 352 (1). P. 34–38.
25. Nathan C. F., Ortenblad N., Madsen K., Djurhu us M. S. Antioxidant status and lipid peroxidation after short-term maximal exercise in trained and untrained humans // Am. J. Physiol. 1997. Vol. 272 (4). Р. 1258–1263.
26. Hwang S. J., Ballantyne C. M., Sharrett A. R. et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases (ARIC) // Circulation. 1997. Vol. 96. Р. 4219–4225.
27. Spiecker M., Peng H. B., Liao J. K. Inhibition of endothelial vascular cell adhesion molecule-1 expression bynitric oxide involves the induction and nuclear translocation of NfkB // J. Biol. Chem. 1997. Vol. 272. P. 30969–30974.
28. Stangl H., Hyatt M., Hobbs H. Transport of Lipids from High and Low Density Lipoproteins via Scavenger Receptor-BI // J. Biol. Chem. 1999. Vol. 274, Issue 46. P. 32692–32698.
29. Blumenthal J. A., O’Connor C., Hinderliter A. et al. Psychosocial factors and coronary disease. A national multicenter clinical trial (ENRICHD) with a North Carolina focus // N. C. Med. J. 1997. Vol. 58. Р. 440–444.
30. Laursen J. B., Rajagopalan S., Galis Z. et al. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension // Circulation. 1997. Vol. 95. P. 588–593.
31. Yokode M., Ueyama K., Arai N. H. et al. Modification of high- and low-density lipoproteins by cigarette smoke oxidants // Ann. N.Y. Acad. Sci. 1996. Vol. 786. Р. 245–251.
32. Zafari A. M., Ushio-Fukai M., Akers M. et al. Role of NADH / NADPH oxidase-derived H<sub>2</sub>O<sub>2</sub> in angioten-sin II-induced vascular hypertrophy // Hypertension. 1998. Vol. 32 (30). P. 488–495.
33. Shephard G., Cobbe S. M., Ford J. еt al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group (WOSCOPS) // N. Engl. J. Med. 1995. Vol. 333. P. 1301–1307.
34. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) // Lancet. 1994. Vol. 344. Р. 1383–1389.
35. Vincent H. K., Powers S. K., Stewart D. J. et al. Obesity is associated with in-creased myocardial oxidative stress. Dept. of Exercise Sport Sci., Center Exercise Sci., Univ. of Florida, Gainesville, USA // Int. J. Obes. Relat. Metab. Disord. 1999. Vol. 23. P. 67–74.
36. Sen-Banerjee S., Siles X., Campos H. Tobacco Smoking Modifies Association Between Gln-Arg192 Polymorphism of Human Paraoxonase Gene and Risk of Myocardial Infarction // Arteriosclerosis, Thrombosis, and Vascular Biology. 2000. Vol. 20. Р. 2120–2128.
37. Kasim-Karakas S. E. Impact of n-3 fatty acids on lipoprotein metabolism // Current Opinion in Lipidology. 1995. Vol. 6. Р. 167–171.
38. Sanchez-Quesada J. L., Homs-Serradesanferm R., Serrat-Serrat J. et al. Increase of LDL suscepti bility to oxidation occurring after intense, long duration aerobic exercise // Atherosclerosis. 1995. Vol. 118. Р. 297-305.
Review
For citations:
Vorobiova E.N., Simonova G.I., Vorobiov R.I., Leschenko I.G. Free-radical oxidation and atherosclerosis. Ateroscleroz. 2010;6(2):20-27. (In Russ.)
Views:
292
Email this article 